These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 7966569

  • 1. Enhanced responsiveness to nuclear factor kappa B contributes to the unique phenotype of simian immunodeficiency virus variant SIVsmmPBj14.
    Dollard SC, Gummuluru S, Tsang S, Fultz PN, Dewhurst S.
    J Virol; 1994 Dec; 68(12):7800-9. PubMed ID: 7966569
    [Abstract] [Full Text] [Related]

  • 2. Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism.
    Maciaszek JW, Talmage DA, Viglianti GA.
    J Virol; 1994 Oct; 68(10):6598-604. PubMed ID: 8083995
    [Abstract] [Full Text] [Related]

  • 3. Simian immunodeficiency viruses containing mutations in the long terminal repeat NF-kappa B or Sp1 binding sites replicate efficiently in T cells and PHA-stimulated PBMCs.
    Zhang J, Novembre F, Rabson AB.
    Virus Res; 1997 Jun; 49(2):205-13. PubMed ID: 9213395
    [Abstract] [Full Text] [Related]

  • 4. Molecular clones from a non-acutely pathogenic derivative of SIVsmmPBj14: characterization and comparison to acutely pathogenic clones.
    Dewhurst S, Embretson JE, Fultz PN, Mullins JI.
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1179-87. PubMed ID: 1503826
    [Abstract] [Full Text] [Related]

  • 5. Simian-human immunodeficiency virus (SHIV) containing the nef/long terminal repeat region of the highly virulent SIVsmmPBj14 causes PBj-like activation of cultured resting peripheral blood mononuclear cells, but the chimera showed No increase in virulence.
    Stephens EB, Mukherjee S, Liu ZQ, Sheffer D, Lamb-Wharton R, Leung K, Zhuge W, Joag SV, Li Z, Foresman L, Adany I, Narayan O.
    J Virol; 1998 Jun; 72(6):5207-14. PubMed ID: 9573293
    [Abstract] [Full Text] [Related]

  • 6. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P, Kwon H, Clarke M, Lin R, Sonenberg N, Wainberg M, Hiscott J.
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [Abstract] [Full Text] [Related]

  • 7. Induction of fas ligand expression by an acutely lethal simian immunodeficiency virus, SIVsmmPBj14.
    Hodge S, Novembre FJ, Whetter L, Gelbard HA, Dewhurst S.
    Virology; 1998 Dec 20; 252(2):354-63. PubMed ID: 9878614
    [Abstract] [Full Text] [Related]

  • 8. Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes.
    Krebs FC, Mehrens D, Pomeroy S, Goodenow MM, Wigdahl B.
    J Biomed Sci; 1998 Dec 20; 5(1):31-44. PubMed ID: 9570512
    [Abstract] [Full Text] [Related]

  • 9. Replication of an acutely lethal simian immunodeficiency virus activates and induces proliferation of lymphocytes.
    Fultz PN.
    J Virol; 1991 Sep 20; 65(9):4902-9. PubMed ID: 1870205
    [Abstract] [Full Text] [Related]

  • 10. Molecular and biological analyses of quasispecies during evolution of a virulent simian immunodeficiency virus, SIVsmmPBj14.
    Tao B, Fultz PN.
    J Virol; 1995 Apr 20; 69(4):2031-7. PubMed ID: 7884848
    [Abstract] [Full Text] [Related]

  • 11. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus.
    Sparger EE, Shacklett BL, Renshaw-Gegg L, Barry PA, Pedersen NC, Elder JH, Luciw PA.
    Virology; 1992 Mar 20; 187(1):165-77. PubMed ID: 1310554
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Stimulation of a human T-cell clone with anti-CD3 or tumor necrosis factor induces NF-kappa B translocation but not human immunodeficiency virus 1 enhancer-dependent transcription.
    Hazan U, Thomas D, Alcami J, Bachelerie F, Israel N, Yssel H, Virelizier JL, Arenzana-Seisdedos F.
    Proc Natl Acad Sci U S A; 1990 Oct 20; 87(20):7861-5. PubMed ID: 2146676
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pentoxifylline inhibits HIV-1 LTR-driven gene expression by blocking NF-kappa B action.
    Biswas DK, Dezube BJ, Ahlers CM, Pardee AB.
    J Acquir Immune Defic Syndr (1988); 1993 Jul 20; 6(7):778-86. PubMed ID: 8509980
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
    Jeeninga RE, Hoogenkamp M, Armand-Ugon M, de Baar M, Verhoef K, Berkhout B.
    J Virol; 2000 Apr 20; 74(8):3740-51. PubMed ID: 10729149
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.